The FDA approved the first orally disintegrating birth control pill for people who have difficulty swallowing their medication, the agency announced in a press release.
The dissolvable combined oral contraceptive of norethindrone acetate and ethinyl estradiol pill (Femlyv, Millicent), was first approved in the U.S. for the prevention of pregnancy as a swallowable tablet in 1968.
"Femlyv is the first FDA approved dissolvable birth control pill, designed for individuals who have trouble swallowing their medication," Janet Maynard, MD, MHS, director of the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine in the FDA's Center for Drug Evaluation and Research, said in the release. "There are many variables that might cause someone to have difficulty swallowing. This drug provides another treatment option and expands access to this form of contraception for individuals who may have experienced those challenges."
According to the full prescribing information, the pill should be taken once daily by placing on the tongue, allowing the pill to disintegrate and then drinking 8 oz of water. Pill packs come with 24 green “active” pills and four white inert pills, all taken once daily at the same time of day.
The most common adverse reactions to Femlyv are headache, vaginal candidiasis, nausea, menstrual cramps, breast tenderness, bacterial vaginitis, abnormal cervical smear, acne, mood swings and weight gain.